Kevin S. Blair - Feb 17, 2022 Form 4 Insider Report for SYNOVUS FINANCIAL CORP (SNV)

Signature
/s/ Mary Maurice Young
Stock symbol
SNV
Transactions as of
Feb 17, 2022
Transactions value $
$0
Form type
4
Date filed
2/22/2022, 04:14 PM
Previous filing
Feb 15, 2022
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
holding SNV Common Stock 88.8K Feb 17, 2022 Direct
holding SNV Fixed/Floating Rate Non-Cum Perpetual Preferred Stock Ser D 2K Feb 17, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNV Performance Stock Units Award $0 +29.8K +52.62% $0.00 86.3K Feb 17, 2022 Common Stock 29.8K Direct F1
transaction SNV Restricted Stock Units Award $0 +19.8K +92.48% $0.00 41.3K Feb 17, 2022 Common Stock 19.8K Direct F2

Explanation of Responses:

Id Content
F1 These shares are subject to performance stock units (the "PSUs"). The PSUs have a service-based vesting component as well as a performance vesting requirement. Under the service-based vesting component, the PSUs vest 100% after three years subject to the reporting person's continued employment with Synovus. Under the performance vesting component, two performance measures (weighted average return on tangible common equity and relative total shareholder return) are measured over a three-year performance period, with each measure impacting one-half of the PSUs awarded to the reporting person. The actual payout of the PSUs may range from 0% to 150% of the target amount based upon the results of the two performance measures during the performance period compared to the performance objective approved by the Compensation and Human Capital Committee of Synovus' Board of Directors.
F2 These shares are subject to restricted stock units that will be settled in cash upon vesting. The units vest 1/3 each year over a three-year period subject to the reporting person's continued employment with Synovus.